What is Doseology Sciences?
Doseology Sciences operates within the consumer health and life sciences industry, focusing on the development and commercialization of innovative oral stimulant and nutraceutical products. The company's offerings are designed to enhance energy, focus, and cognitive performance. Described as a science-driven brand, Doseology Sciences leverages advanced formulation and delivery technologies, integrating functional ingredients with research-based development. Its target market includes wellness-oriented consumers across evolving health landscapes. The brand emphasizes a commitment to regulatory compliance and transparent labeling, fostering consumer trust and long-term credibility in its advanced wellness solutions.
How much funding has Doseology Sciences raised?
Doseology Sciences has raised a total of $2M across 1 funding round:
Stock/Share Issuance
$2M
Stock/Share Issuance (2026): $2M, investors not publicly disclosed
What's next for Doseology Sciences?
The recent major strategic investment of $2M positions Doseology Sciences for significant scaling and market expansion. This capital injection, part of a $2M overall financing, suggests the company is moving beyond its initial development phases and is poised to further innovate and broaden its product portfolio. Future strategic initiatives will likely involve enhancing its direct-to-consumer channels, expanding research and development into new cognitive and energy-enhancing formulations, and potentially exploring strategic partnerships within the broader health and wellness ecosystem. The company's focus on science-backed products and regulatory adherence provides a strong foundation for sustained growth and market leadership.
See full Doseology Sciences company page
